{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:37:18Z","timestamp":1790861838726,"version":"4.1.0"},"reference-count":56,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,8]],"date-time":"2009-12-08T00:00:00Z","timestamp":1260230400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction Biology"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Methadone may cause respiratory depression. We aimed to understand methadone\u2010related effects on ventilation as well as each opioid\u2010receptor (OR) role. We studied the respiratory effects of intraperitoneal methadone at 1.5, 5, and 15\u2003mg\/kg (corresponding to 80% of the lethal dose\u201050%) in rats using arterial blood gases and plethysmography. OR antagonists, including intravenous 10\u2003mg\/kg\u2010naloxonazine at 5 minutes (mu\u2010OR antagonist), subcutaneous 30\u2003mg\/kg\u2010naloxonazine at 24 hours (mu1\u2010OR antagonist), 3\u2003mg\/kg\u2010naltrindole at 45 minutes (delta\u2010OR antagonist) and 5\u2003mg\/kg\u2010Nor\u2010binaltorphimine at 6 hours (kappa\u2010OR antagonist) were pre\u2010administered. Plasma concentrations of methadone enantiomers were measured using high\u2010performance liquid chromatography coupled to mass\u2010spectrometry. Methadone dose\u2010dependent inspiratory time (T<jats:sub>I<\/jats:sub>) increase tended to be linear. Respiratory depression was observed only at 15\u2003mg\/kg and characterized by an increase in expiratory time (T<jats:sub>E<\/jats:sub>) resulting in hypoxemia and respiratory acidosis. Intravenous naloxonazine completely reversed all methadone\u2010related effects on ventilation, while subcutaneous naloxonazine reduced its effects on pH (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05), PaCO<jats:sub>2<\/jats:sub>(<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and T<jats:sub>E<\/jats:sub>(<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) but only partially on T<jats:sub>I<\/jats:sub>(<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Naltrindole reduced methadone\u2010related effects on T<jats:sub>E<\/jats:sub>(<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001). Nor\u2010binaltorphimine increased methadone\u2010related effects on pH and PaO<jats:sub>2<\/jats:sub>(<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) Respiratory effects as a function of plasma<jats:italic>R<\/jats:italic>\u2010methadone concentrations showed a decrease in PaO<jats:sub>2<\/jats:sub>(EC<jats:sub>50<\/jats:sub>: 1.14\u2003\u00b5g\/ml) at lower concentrations than those necessary for PaCO<jats:sub>2<\/jats:sub>increase (EC<jats:sub>50<\/jats:sub>: 3.35\u2003\u00b5g\/ml). Similarly, increased T<jats:sub>I<\/jats:sub>(EC<jats:sub>50<\/jats:sub>: 0.501\u2003\u00b5g\/ml) was obtained at lower concentrations than those for T<jats:sub>E<\/jats:sub>(EC<jats:sub>50<\/jats:sub>: 4.83\u2003\u00b5g\/ml). Methadone\u2010induced hypoxemia is caused by mu\u2010ORs and modulated by kappa\u2010ORs. Additionally, methadone\u2010induced increase in T<jats:sub>E<\/jats:sub>is caused by mu1\u2010 and delta\u2010opioid receptors while increase in T<jats:sub>I<\/jats:sub>is caused by mu\u2010ORs.<\/jats:p>","DOI":"10.1111\/j.1369-1600.2009.00184.x","type":"journal-article","created":{"date-parts":[[2010,1,13]],"date-time":"2010-01-13T14:10:15Z","timestamp":1263391815000},"page":"62-80","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["PRECLINICAL STUDY: Mechanisms of respiratory insufficiency induced by methadone overdose in rats"],"prefix":"10.1111","volume":"15","author":[{"given":"Lucie","family":"Chevillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"M\u00e9garbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric J.","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ris\u00e8de","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Decl\u00e8ves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ricordel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,8]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010263431705"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0034-5687(70)90056-3"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000117841.81730.2B"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1067\/mcp.2001.116793"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3565(25)10244-9","article-title":"Apparent pA2 analysis on the respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and Mr2033 in rhesus monkeys","volume":"264","author":"Butelman ER","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(96)00571-7"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200105000-00021"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-8-200510180-00028"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0022-3565(25)10187-0","article-title":"The kappa opioid agonist U\u201050,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats","volume":"264","author":"Dosaka\u2010Akita K","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1983.tb10547.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2004.05.002"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1986.tb11121.x"},{"key":"e_1_2_6_15_1","first-page":"25","article-title":"Human pharmacology and addictiveness of certain dextroisomers of synthetic analgesics","volume":"14","author":"Fraser HF","year":"1962","journal-title":"Bull Narcotics"},{"key":"e_1_2_6_16_1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0022-3565(25)33602-5","article-title":"Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration","volume":"225","author":"Geller EB","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0307601101"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-22-j0007.2000"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/65.1.107"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(84)90248-X"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3565(25)25010-8","article-title":"Respiratory effects of morphine in awake unrestrained rats","volume":"237","author":"Van Den Hoogen RH","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2008.08.006"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0022-3565(25)21059-X","article-title":"Sympathoadrenal, cardiovascular and blood gas responses to highly selective mu and delta opioid peptides","volume":"251","author":"Kiritsy\u2010Roy JA","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00937-6"},{"key":"e_1_2_6_25_1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-3565(25)32504-8","article-title":"Methadone: radioimmunoassay and pharmacokinetics in the rat","volume":"217","author":"Ling GFS","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(86)90333-X"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3565(25)20062-3","article-title":"Separation of opioid analgesia from respiratory depression: evidence for different receptor mechanisms","volume":"232","author":"Ling GS","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.3030470507"},{"key":"e_1_2_6_29_1","first-page":"1088","article-title":"Chronic hypercapnia during methadone maintenance","volume":"108","author":"Marks CE","year":"1973","journal-title":"Am Rev Respir Dis"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(98)00679-9"},{"key":"e_1_2_6_31_1","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick RP","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1989.tb14620.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-3565(25)21486-0","article-title":"Effects of diazepam on the arterial blood gas concentrations and pH of adults rats acutely and chronically exposed to methadone","volume":"230","author":"McCormick GY","year":"1984","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02221.x"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90595-8"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0953-816x.2001.01547.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300527"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.01.004"},{"key":"e_1_2_6_39_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-3565(25)32200-7","article-title":"Naloxonazone, a long\u2010acting opiate antagonist: effects on analgesia in intact animals and on opiate receptor binding in vitro","volume":"214","author":"Pasternak GW","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90470-8"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90427-8"},{"key":"e_1_2_6_42_1","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0022-3565(25)33655-4","article-title":"Cardiovascular and respiratory effects of mu\u2010, delta\u2010 and kappa\u2010opiate agonists microinjected into the anterior hypothalamic brain area of awake rats","volume":"225","author":"Pfeiffer A","year":"1983","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90155-5"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2008.00273.x"},{"key":"e_1_2_6_45_1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned kappa\u2010, delta\u2010, and mu\u2010opioid receptors","volume":"45","author":"Raynor K","year":"1994","journal-title":"Mol Pharmacol"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(77)90831-2"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/142.4.895"},{"key":"e_1_2_6_48_1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0022-3565(25)21044-8","article-title":"Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats","volume":"246","author":"Spencer RL","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_49_1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3565(24)37867-X","article-title":"Delta\u2010opioid ligands reverse alfentanil\u2010induced respiratory depression but not antinociception","volume":"287","author":"Su YF","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(98)00141-7"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4684-0101-1"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00068-8"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(98)00238-X"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1975182180"},{"key":"e_1_2_6_55_1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3565(25)32972-1","article-title":"Pharmacological characterization in vivo of the novel opiate, beta\u2010funaltrexamine","volume":"220","author":"Ward SJ","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_56_1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0022-3565(25)31691-5","article-title":"Acute and chronic methadone exposure in adult rats: studies on arterial blood gas concentrations and pH","volume":"209","author":"White WJ","year":"1979","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6181"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1369-1600.2009.00184.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1369-1600.2009.00184.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T18:10:23Z","timestamp":1739729423000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1369-1600.2009.00184.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,8]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1369-1600.2009.00184.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1369-1600.2009.00184.x","archive":["Portico"],"relation":{},"ISSN":["1355-6215","1369-1600"],"issn-type":[{"value":"1355-6215","type":"print"},{"value":"1369-1600","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,8]]},"assertion":[{"value":"2009-12-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}